Table 2.
Baseline Characteristics of Subjects With CHA2DS2‐VASc Score of 0 or 1
| Stroke (N=462) | Control (N=508) | P Value | |
|---|---|---|---|
| Age, y | 59.8±8.3 | 51.3±9.6 | <0.001 |
| Age ≥65 y | 114 (24.7%) | 28 (5.5%) | <0.001 |
| Female sex | 62 (13.4%) | 56 (11.0%) | 0.297 |
| Persistent AF | 246 (53.7%) | 264 (52.0%) | 0.633 |
| CHF | 18 (3.9%) | 30 (5.9%) | 0.196 |
| HTN | 112 (24.2%) | 173 (34.1%) | 0.001 |
| DM | 17 (3.7%) | 30 (5.9%) | 0.144 |
| Vascular disease | 3 (0.6%) | 12 (2.4%) | 0.058 |
| CHA2DS2‐VASc score | 0.317 | ||
| 0 | 136 (29.4%) | 179 (35.2%) | |
| 1 | 326 (70.6%) | 329 (64.8%) | |
| Sex with CHA2DS2‐VASc score | |||
| Male with 0 | 136 (29.4%) | 179 (35.2%) | 0.063 |
| Male with 1 | 264 (57.1%) | 273 (53.7%) | 0.317 |
| Female with 0 | 62 (13.4%) | 56 (11.0%) | 0.297 |
| LVEF, % | 59.0 (11.0) | 62.5 (7.5) | 0.123 |
| LA dimension, mL | 43.1 (9.0) | 39.5 (7.5) | <0.001 |
| Hb, g/dL | 14.4 (2.2) | 14.4 (2.6) | 0.864 |
| RDW, % | 13.2 (1.2) | 13.1 (0.9) | 0.096 |
| LDL, mg/dL | 102.0 (44.5) | 100.0 (39.0) | 0.239 |
| CCr, mL/min | 80.8 (31.9) | 100.0 (32.3) | <0.001 |
| Uric acid, mg/mL | 5.6 (2.1) | 5.1 (2.2) | <0.001 |
| NT‐proBNP pg/mL | 480.0 (574.0) | 76.8 (171.6) | <0.001 |
Data are presented as mean±SD or median (interquartile range). AF indicates atrial fibrillation; CCr, creatinine clearance rate; CHA2DS2‐VASc, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke or transient ischemic attack, vascular disease, age 65 to 74 years; CHF, congestive heart failure; DM, diabetes mellitus; vascular disease, peripheral artery disease, myocardial infarction or aortic plaque; Hb, hemoglobin; HTN, hypertension; LA, left atrium; LDL, low‐density lipoprotein; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro B‐type natriuretic peptide; RDW, red blood cell distribution width.